Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biofabrication & Biomanufacturing Europe 2019

Fabien Guillemot's Biography



Fabien Guillemot, Chief Executive Officer, Poietis

Dr. Fabien Guillemot is the CEO and founder of Poietis, company devoted to the fabrication of complex and customized tissues for regenerative medicine and pharmaceutical applications by Laser-Assisted Bioprinting. He obtained his PhD in Materials Science in 2000 from the National Institute for Applied Sciences (France) and was appointed Senior Researcher in 2005 at the National Institute for Health and Medical Research (INSERM, France). PI of the group Tissue Engineering Assisted by Laser, he accomplished pioneered works on in vivo and in situ bioprinting. In 2009, Dr. Guillemot organized the International Conference on Bioprinting and Biofabrication in Bordeaux. He is the author of more than 50 articles in peer-reviewed journals and about 40 invited conferences.

Fabien Guillemot Image

Tissue Manufacturing by Bioprinting: Challenges and Opportunities

Thursday, 20 June 2019 at 14:00

Add to Calendar ▼2019-06-20 14:00:002019-06-20 15:00:00Europe/LondonTissue Manufacturing by Bioprinting: Challenges and OpportunitiesBiofabrication and Biomanufacturing Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Despite substantial investments to meet clinical and commercial expectations, and while scientific achievements at the preclinical research stage have sometimes been impressive, scaffold-based Tissue Engineering approaches are struggling to find the way to therapeutic and industrial success. Main challenges for the manufacturing of tissue engineered ATMPs concern the improvement of the standardisation of manufacturing processes, tissue functionality, and cost-effectiveness and profitability of related treatments.
 
Based on our experience in the field of bioprinting, we discuss how this technology – thanks to its characteristics resulting from the convergence of automation, biology and digital technology – should make it possible to overcome current tissue manufacturing bottlenecks and also provide new opportunities.


Add to Calendar ▼2019-06-20 00:00:002019-06-21 00:00:00Europe/LondonBiofabrication and Biomanufacturing Europe 2019Biofabrication and Biomanufacturing Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com